Diese Präsentation wurde erfolgreich gemeldet.
Die SlideShare-Präsentation wird heruntergeladen. ×

Lessons from the UK: Data access, patient trust & real-world impact with health data science

Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige

Hier ansehen

1 von 32 Anzeige

Lessons from the UK: Data access, patient trust & real-world impact with health data science

Herunterladen, um offline zu lesen

Slides supporting presentation given at the virtual Beilstein Open Science Symposium in October 2021.

Abstract:
Health Data Research UK’s mission is to unite the UK’s health data to enable discoveries that improve people’s lives. Our 20-year vision is for large scale data and advanced analytics to benefit every patient interaction, clinical trial, biomedical discovery and enhance public health. A key part of HDR UK’s vision is our data portal, the Innovation Gateway. The Gateway facilitates discovery of healthcare data and simplifies data request procedures across multiple data custodians. The Gateway contains metadata on a variety of datasets, including those related to COVID-19, cardiovascular, maternal health, emergency care, primary care, secondary care, acute care, palliative care, biobanks, research cohorts and deeply phenotyped patient cohorts.
From the outset HDR UK has sought the voices, views and experiences of patient and lay-public groups to ensure there is transparency and clear public benefit in the use of the UK’s health data. Patient and public involvement is key to making the Gateway accessible, transparent and to ensure public confidence in research access to health data. The importance of public outreach combined with providing research access to data is illustrated with HDR UK’s contribution to the UK’s coronavirus pandemic response. HDR UK was tasked by the UK’s Chief Scientific Office to build and facilitate the infrastructure to support the National Core Studies, providing key insights on the evolving situation to UK policy makers during the course of the pandemic.
In this talk, I will show how HDR UK is enabling open science by facilitating the discovery of health data, and simplifying the process of requesting access to multiple datasets. I’ll discuss HDR UK’s approach to embedding transparency on research data usage for patients and public, and summarise some of the key ways in which HDR UK has contributed to the coronavirus pandemic.

Slides supporting presentation given at the virtual Beilstein Open Science Symposium in October 2021.

Abstract:
Health Data Research UK’s mission is to unite the UK’s health data to enable discoveries that improve people’s lives. Our 20-year vision is for large scale data and advanced analytics to benefit every patient interaction, clinical trial, biomedical discovery and enhance public health. A key part of HDR UK’s vision is our data portal, the Innovation Gateway. The Gateway facilitates discovery of healthcare data and simplifies data request procedures across multiple data custodians. The Gateway contains metadata on a variety of datasets, including those related to COVID-19, cardiovascular, maternal health, emergency care, primary care, secondary care, acute care, palliative care, biobanks, research cohorts and deeply phenotyped patient cohorts.
From the outset HDR UK has sought the voices, views and experiences of patient and lay-public groups to ensure there is transparency and clear public benefit in the use of the UK’s health data. Patient and public involvement is key to making the Gateway accessible, transparent and to ensure public confidence in research access to health data. The importance of public outreach combined with providing research access to data is illustrated with HDR UK’s contribution to the UK’s coronavirus pandemic response. HDR UK was tasked by the UK’s Chief Scientific Office to build and facilitate the infrastructure to support the National Core Studies, providing key insights on the evolving situation to UK policy makers during the course of the pandemic.
In this talk, I will show how HDR UK is enabling open science by facilitating the discovery of health data, and simplifying the process of requesting access to multiple datasets. I’ll discuss HDR UK’s approach to embedding transparency on research data usage for patients and public, and summarise some of the key ways in which HDR UK has contributed to the coronavirus pandemic.

Anzeige
Anzeige

Weitere Verwandte Inhalte

Diashows für Sie (20)

Ähnlich wie Lessons from the UK: Data access, patient trust & real-world impact with health data science (20)

Anzeige

Weitere von Varsha Khodiyar (20)

Aktuellste (20)

Anzeige

Lessons from the UK: Data access, patient trust & real-world impact with health data science

  1. 1. Lessons from the UK: Data access, patient trust & real-world impact with health data science Varsha Khodiyar, PhD HDR UK, Data Access Project Manager Beilstein Open Science Symposium, 5 - 7 October 2021
  2. 2. Agenda • About Health Data Research UK • Facilitating data access through The Innovation Gateway • Importance of transparency for patients and the lay public • HDR UK’s impact on the coronavirus pandemic | 2
  3. 3. Health Data Research UK
  4. 4. Where this all started… The need for a robust health data research infrastructure in the UK | 4 Industrial Strategy for Life Sciences (November 2017) Hubs for health data research (digital innovation hubs) HDR UK Funded by: British Heart Foundation, Chief Scientists Office (Scotland), Health and Care Research Wales, Health & Social Care R&D N. Ireland, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Medical Research Council, National Institute for Health Research, Wellcome, UK Research and Innovation Health Data Research UK asked to lead delivery of this programme on behalf of UK Research and Innovation in September 2018 HDR UK aims to realise the potential of UK’s health data resources for patient and public benefit Four-year programme launched in September 2018
  5. 5. HDR UK’s mission is to unite the UK’s health data to enable discoveries that improve people’s lives Our 20-year vision is for large scale data and advanced analytics to benefit every patient interaction, clinical trial, biomedical discovery and enhance public health. | 5
  6. 6. HDR UK is a UK-wide virtual institute, working across all four nations HEALTH DATA RESEARCH HUBS BREATHE DATA-CAN Discover-NOW Gut Reaction INSIGHT PIONEER NHS DigiTrials BHF Data Science Centre TRAINING LOCATIONS (Masters and PhD) Belfast Birmingham Bristol Cambridge Edinburgh Exeter Leeds London Manchester Oxford CENTRAL TEAM OFFICES Wellcome Trust Great Ormond Street DRIVE Unit RESEARCH LOCATIONS HDR UK Cambridge HDR UK London HDR UK Midlands HDR UK North HDR UK Oxford HDR UK Scotland HDR UK South-West HDR UK Wales and Northern Ireland | 6
  7. 7. Bringing together a complex data custodian landscape
  8. 8. Focused on national research priority areas | 8
  9. 9. The infrastructure to deliver this strategy USING HEALTH DATA
  10. 10. Data access via ‘The Innovation Gateway’
  11. 11. The Innovation Gateway for health data discovery and access www.healthdatagateway.org | 12 “Really impressed with this resource. I think as a gateway to search by data type and indication, it’s a really powerful tool.“ David Leather, GSK
  12. 12. Several options for discovering different types of health data | 13
  13. 13. Gain insight into data reusability prior to requesting access | 14 Technical details & metadata wheel Data utility
  14. 14. Layout for illustration purpose only Health Data Gateway Query Engine Cohort Query Dataset 1: 20K Dataset 2: 3K Dataset 3: 1K … Researchers Cohort Discovery on the Innovation Gateway Co-vars Inc. Crit Exc. Crit Custodian controlled Cohort Query Agents Query Processing Query Results Total Patients: 23K Statistical Disclosure Control Policies: • User validation (e.g. Bona-fide Researcher) • Low number suppression (e.g. >50) • Query Count binning (e.g. 50, 60, 70, -) • Query Rate limiting • Researchers can reuse the cohort query to define their research protocol when submitting their data access request • Researchers will be able to reuse and compare cohort definitions between similar protocols • Cohort definitions will be able to reuse phenotype definitions (asthma, diabetes) without resorting to using ICD-10, Read, SNOMED-CT codes Solution: Cohort Discovery enables researchers to discover, assess and request access to potential datasets that exactly match the research project cohort definition using standardized inclusion & exclusion criteria and co-variates Datasets with female patients between 18-35 who have asthma and diabetes and who are not smokers and not pregnant Cohort Definition Demo: https://www.youtube.com/watch?v=L50nqIR6k98
  15. 15. Data Access Request workflow | 16 • HDR UK works with data custodians to incorporate their due diligence processes into the Five Safes form • Five Safes form provides a standardized way for researchers to request access to data held by multiple data custodians • Data custodians maintain decision making responsibility on whether or not to grant data access for each request received
  16. 16. Data access & management based on the Five Safes framework | 17 https://blog.ons.gov.uk/2017/01/27/the-five-safes-data-privacy-at-ons/ 1. Safe People e.g. Approved researchers scheme 2. Safe Projects Project proposal reviewed by governance board convened by the data custodian 3. Safe Settings Data access provided within a Trusted Research Environment 4. Safe Data Data supplied as deidentified to minimize identification of individuals 5. Safe Output Analysis outputs checked by data custodians prior to release
  17. 17. A TRE is a Trusted Research Environment. Also known as ‘Data Safe Havens’, TREs are highly secure computing environments that provide remote access to health data for approved researchers to use in research that can save and improve lives. What is a TRE? Custodian makes deidentified data available within TRE after data access request approval. Why are they important? http://www.hdruk.ac.uk/trustedresearchenvironments TRE green paper doi.org/10.5281/zenodo.4594703 (2020) Researcher is able to specify the tools and software they need within the TRE to enable their study. Data analysis carried out within the TRE and outputs checked for sensitivity by data custodian.
  18. 18. Providing researchers with tools, training and standards | 19 www.hdruk.ac.uk/help-with-your-data/ Data Utility Matrix International links Data Quality Tool Evaluation Data Officers Groups / Hubs Position/consultation papers Projects (Eg COVID-19) Metadata completeness SIGs (FHIR, Synthetic data,etc)
  19. 19. We are seeing people discovering UK health data from across the world | 20 25,609 visits from around the world (1st Jan 2021 to 3rd Oct 2021)
  20. 20. Research transparency via ‘Patient and Public Involvement and Engagement (PPIE)’
  21. 21. | 22 I am glad you're involving me from what seems to be the beginning so that you can actually take my concerns and address them whilst helping the greater good Patient / Public Voice Rep “ It is essential that the public is included in this ground-breaking work. Margaret Rogers Member of the HDR UK Public Advisory Board “ 92 people consulted to inform decisions on methods and process for clinical trial recruitment Consultation on COVID work across 7 UK- wide patient and public networks with 168 responses. 16,500 contacts with patient & public contributors across the institute in 2020 Strong Public Advisory Board providing strategic guidance on all our work An exemplar of working with public and patients
  22. 22. Monthly Open Door meetings aimed at the lay public | 23
  23. 23. Gateway Data Use Registers – closing the loop A data use register offers a public record of how data is being used, by who and most importantly for what purpose – Outputs linked to data | 24 • Search >600 datasets, tools, papers, training • Data visualisations • Query data via cohort discovery (depth & breadth) • API Driven • Data Access Requests • Metadata Catalogues • 5 Safes framework • GA4GH Passports & Visas • Open ID Connect integration • LinkedIn & Google integration • OpenAthens integration • TRE integrations with Cohort Discovery • Publications from multiple TREs • TRE Green Paper • TRE white paper & reference architecture • TRE federation & interoperability 60% 40% 20% DISCOVERY ACCESS ANALYSIS = % of total features built OUTPUT SHARING FOR RE-USE 10% • Publication outputs from data used • Standards for Data use registers • Datasets DOIs • Automatic output linking to data • Data Access Request/Data use register integration
  24. 24. Impact of HDR UK on the coronavirus pandemic
  25. 25. Working in partnership to answer priority questions - The National Core Studies | 26 Surveillance & Epidemiology Longitudinal Health and Wellbeing Transmission & Environment Immunity Clinical Trials Infrastructure & Support Vaccines Therapeutics Professor Ian Diamond (ONS) Professor Nishi Chaturvedi (UCL) Divya Chadha Manek (VTF/NIHR) Professor Patrick Chinnery (MRC) Professor Andrew Curran (HSE) Professor Paul Moss (University of Birmingham) Collecting and analysing data to understand incidence and prevalence broadly and in different settings in order to inform response measures. Understanding the impact of Covid-19 on long term health (including long covid) to inform the design of mitigating policies. Establishing infrastructure to run large scale trials for Covid-19 drugs and vaccines without disrupting trials for other diseases. Taking samples to aid understanding of transmission of the disease in workplace, transport and public places. Understanding serology as a useable predictor of immunity against Covid. Data and Connectivity Professor Andrew Morris (HDR UK working with ONS) Making UK-wide health and administrative data available for linkage and accessible to catalyse Covid-19 research.
  26. 26. Our three key priorities at the onset of the COVID-19 pandemic | 27 1 2 3 Co-ordinate and connect national data science driven research efforts related to COVID-19 Accelerate access to UK-wide priority data relevant to COVID-19 for research Leverage the best of the UK’s health data science capability to address the wider impact of the COVID- 19 pandemic, supporting vulnerable groups that will be hardest hit Support the UK government response through regular reporting to SAGE
  27. 27. | 28 Enabled daily access to positive C-19 test results within 24 hours to increase recruitment. Support also included: • Daily problem solving and management scrums • In-depth engagement with the ICO • A public survey with over 90 responses • Engagement with multiple data custodians • Review by NHS Digital’s IGARD • NHS Digital’s Trial team are now addressing the remaining actions to support data flow Provides confidence in concept for future trials that require incident COVID cases I'm so pleased you're looking into this as this is something that can actually make a difference. Patient / Public Voice Rep “ Patient input shaping use of data for PRINCIPLE clinical trial “The creative energy that has gone into making the progress you outline could well be saving lives soon. You are making history.” Chris Butler, Principle Trial Lead
  28. 28. Important discoveries by researchers using HDR UK infrastructure | 29 Better Care Understanding Causes of Disease Clinical Trials Public Health High-resolution mapping of COVID cases directly informed public health policy in Wales Understanding the impact of COVID-19 on vulnerable people with health conditions, including those with cancer and heart disease RECOVERY trial used data to establish that dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19 Genetic sequencing of COVID- 19 to track which strains have resulted in different outbreaks
  29. 29. 30 International COVID-19 Data Alliance (ICODA): advancing open science practice globally Vision To unite international health research data to enable discoveries that benefit everyone, everywhere, by reducing the harm of COVID-19; and enable an efficient data response to future pandemics and other health challenges To build an open international partnership that demonstrates trustworthiness to support a rapid response to COVID-19 and a long-term alliance for making data accessible to researchers and scientists around the world. Mission • Launched on 6 July 2020 • Convened by Health Data Research UK • Focus on Lower and Middle-Income Countries • Supported by the COVID-19 Therapeutics Accelerator • Driver Projects awarded to test the infrastructure and deliver COVID-19 research OurTherapeutics Accelerator Funders Convened by
  30. 30. Summary • HDR UK is uniting the UK’s health data access for researchers. • The Innovation Gateway facilitates discovery and access to health data by researchers. • Increasing the FAIRness of data, by increasing the F, A, I of metadata, and indicating the R of data via metadata assessment. • Demonstration of the importance of patient and lay public involvement in all aspects of health data research. • HDR UK has had an important role to play in the UK’s response to the pandemic. • HDR UK is laying the foundations for an international alliance to enable a data-centric response to COVID-19 and other health challenges | 31
  31. 31. Thank you Find out more: www.hdruk.ac.uk @HDR_UK Visit the Gateway: healthdatagateway.org Find out about the UK Alliance: healthdata.org

×